Efficacy of Circulating Tumor Cell Count–Driven vs...

  • Main
  • 2020 / 11
  • Efficacy of Circulating Tumor Cell Count–Driven vs...
JAMA Oncology 2020 / 11

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

Bidard, François-Clément, Jacot, William, Kiavue, Nicolas, Dureau, Sylvain, Kadi, Amir, Brain, Etienne, Bachelot, Thomas, Bourgeois, Hugues, Gonçalves, Anthony, Ladoire, Sylvain, Naman, Hervé, Dal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2020.5660
Date:
November, 2020
File:
PDF, 489 KB
2020
Conversion to is in progress
Conversion to is failed